Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Lisinopril

Unchecked
From Pharmacopedia
Lisinopril
Zestril, Prinivil, Qbrelis

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Common uses
Hypertension0, Heart failure0, Post-myocardial infarction0, Diabetic nephropathy0
Pharmacy
Starting dose
5-10 mg PO once daily (2.5 mg in heart failure, hyponatremia, or volume depletion)
Preparations
2.5, 5, 10, 20, 30, 40 mg tablets; 1 mg/mL oral solution
US FDA Max
80 mg/d
Pharmacology
Routes
Oral
Onset
BP lowering within 1 hour; max effect at 6 hours
Duration
24 hours
Half-life
~12 hours (effective); terminal half-life is biphasic[1]
Bioavailability
~25% (oral; food does not affect absorption)[1]
Pregnancy
Contraindicated in pregnancy (all trimesters); fetal renal injury, oligohydramnios, skull hypoplasia, hypotension. Stop on detection[1]
Legal status
Rx-only in US
Purported mechanism
Lisinopril is a long-acting ACE inhibitor that blocks conversion of angiotensin I to angiotensin II, reducing vasoconstriction, aldosterone secretion, and renal sodium retention.0 Also raises bradykinin, contributing to vasodilation and the characteristic dry cough. Renally cleared, unmetabolized; dose-adjust by eGFR[1].

References

edit
  1. 1.0 1.1 1.2 1.3 FDA Prescribing Information, Zestril (lisinopril), AstraZeneca, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019777s056lbl.pdf